Basic research in the context of the development of medical substances and technologies

  • L. V. Kuznetsova A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
  • L. Yu. Bakhtina Institute of General Pathology and Pathophysiology, Moscow, Russia
  • I. Yu. Malyshev A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; Institute of General pathology and Pathophysiology, Moscow, Russia http://orcid.org/0000-0002-2381-9612
Keywords: pharmaceutical company, drugs, cost, development

Abstract

This brief review discusses challenges of pharmaceutical companies and issues of the most rational relationship between the speed, cost, and quality of the process for drug and technology development (DTD). It was concluded that the experimental design and methods of medical and pharmacological research should be developed on the basis of modern principles and ideas about the essence of DTD stages with a particular emphasis on the high quality of scientific research at the stage of discovery.

Published
2018-12-28
How to Cite
Kuznetsova, L. V., Bakhtina, L. Y., & Malyshev, I. Y. (2018). Basic research in the context of the development of medical substances and technologies. Patogenez (Pathogenesis), 16(3), 84-86. https://doi.org/10.25557/2310-0435.2018.03.84-86
Section
Brief reports